|
Match
|
Document |
Document Title |
|
|
4996061 |
Pharmaceutical composition for piperidinoalkanol-decongestant combination
The present invention relates to a pharmaceutical composition in the form of a multiple-compression tablet comprising (a) a discrete zone made with Formulation (A) which comprises a carrier base...
|
|
|
4983730 |
Water soluble cellulose acetate composition having improved processability and tensile properties
Water soluble cellulose acetate composition having improved processability and tensile properties suitable for application as films, coatings and fibers and comprising one or more lower molecular...
|
|
|
4975283 |
Stabilized enteric coated aspirin granules and process for preparation
A stabilized enteric coated aspirin granule product prepared by commingling the enteric coated aspirin granules with glutamic acid hydrochloride.
|
|
|
4954349 |
Oral magnesium and potassium compositions and use
Solid oral composition for the treatment or prophylaxis of potassium and magnesium deficiency in skeletal and cardiac muscle containing about 3 to about 50 milliequivalent bioavailable potassium,...
|
|
|
4908214 |
Pharmaceutical tablet for the treatment of uraemia
A tablet constituted by (1) a core comprising a mixture of salts formed by a basic α-amino acids and α-keto analogues of branched-chain essential amino acids and (2) a gastroresistant or...
|
|
|
4873090 |
Non-adjuvenated vaccine
An enteral non-adjuvenated monobacterial vaccine comprising killed bacteria gives a better protection against acute episodes of infection in patients with long term chronic lung disease than a...
|
|
|
4871545 |
Pharmaceutical combination of nifedipine and salbutamol
Nifedipine is a well-known calcium antagonist, and salbutamol is a much used bronchodilator. Yet a pharmaceutical combination containing both substances is not known. Prior experience with the...
|
|
|
4865847 |
Gastric mucosa protective agents
Isolated chlorogenic acid or the physiologically acceptable derivatives thereof when used before or simultaneously with the administration of gastric acid secretion-stimulating and/or gastric...
|
|
|
4853230 |
Pharmaceutical formulations of acid labile substances for oral use
Pharmaceutical preparation containing an acid labile compound together with an alkaline reacting compound or an alkaline salt of an acid labile compound optionally together with an alkaline...
|
|
|
4844907 |
Pharmaceutical composition comprising analgesic and anti-inflammatory agent
A pharmaceutical composition in the form of a multiphase (especially a bilayered, optionally coated) tablet. The tablet has a narcotic analgesic phase containing a therapeutically effective...
|
|
|
4840797 |
Confectionery or pharmaceutical product with a sugarless coating obtained by hard coating and method for its preparation
Confectionery or pharmaceutical product with the sugarless coating obtained by hard coating, this coating being essentially crystalline and comprising at least 90% by weight of maltitol.
|
|
|
4810502 |
Pseudoephedrine brompheniramine therapy
A dosage form is disclosed for delivering the beneficial drugs pseudoephedrine and brompheniramine to a biological environment of use.
|
|
|
4803076 |
Controlled release device for an active substance
A device for the controlled release of a substance having useful activity into a fluid medium at a substantially constant rate, said substance contained in a shape which is substantially that of a...
|
|
|
4803081 |
New pharmaceutical preparations with extended release
An extended release perparation of an active compound with very low solubility containing the active compound dissolved or dispersed in a semi-solid or liquid non-ionic solubilizer and whereby the...
|
|
|
4803080 |
Sustained-release theophylline formulation
A sustained-release theophylline formulation, which comprises matrix pellets in which theophylline particles are embedded in a matrix of water-insoluble plastic and which are enclosed by a membrane...
|
|
|
4795645 |
Sustained release tablets of theophylline
The present invention relates to a sustained release tablet comprising an admixture of theophylline and denaturated egg-albumin. The invention relates also to a process for the preparation of said...
|
|
|
4792452 |
Controlled release formulation
A controlled release pharmaceutical formulation is provided which releases a pharmaceutical of a basic character at a controlled rate regardless of the pH of the environment, which formulation...
|
|
|
4789546 |
Multiple-layer tablet with contrasting organoleptic characteristics
A multiple-layer edible tablet is provided which contains a combination of different ingredients in separate layers wherein ingredients in one of the layers exhibits distinct organoleptic...
|
|
|
4786505 |
Pharmaceutical preparation for oral use
Pharmaceutical preparation containing omeprazole together with an alkaline reacting compound or an alkaline salt of omeprazole optionally together with an alkaline compound as the core material,...
|
|
|
4780318 |
Oral pharmaceutical composition
The present invention relates to a new oral pharmaceutical composition having an improved release of the therapeutically active compound present therein, in the lower part of the gastro-intestinal...
|
|
|
4761289 |
Sustained release implant and method for preparing same
A mixture comprising a dispersion of a water-diffusible solid in a solution of a non-aqueous solvent and a substantially water-insoluble polymer is formed. The non-aqueous solvent is removed from...
|
|
|
4756911 |
Controlled release formulation
A controlled release pharmaceutical formulation which undergoes substantially or approaches zero order release of active drug is provided, preferably in the form of a coated tablet, containing a...
|
|
|
4753803 |
Method for simultaneously drying and granulating extract substances from deproteinized calves blood
The invention relates to a fluidized-bed method for simultaneously obtaining the dry matter from aqueous solutions of extract substances from deproteinized calves blood and producing granules which...
|
|
|
4695467 |
Sustained release tablet
The invention relates to a sustained release tablet which comprises easily disintegrable granules containing (a) a drug, (b) a disintegrating agent selected from the group consisting of...
|
|
|
4529583 |
Composition and method of immobilizing emetics and method of treating human beings with emetics
A therapeutic composition is coated with a mixture of an emetic chemical and an inert material. A method for reducing absorption into the body of a being of an emetic chemical while still retaining...
|
|
|
4427648 |
Dipyridamole-containing pharmaceutical form
This invention relates to vehicles for the administration of dipyridamole. More specifically, this invention relates to a method of treating cardiovascular disorders in a host in need of such...
|
|
|
4175119 |
Composition and method to prevent accidental and intentional overdosage with psychoactive drugs
A composition and method of inducing emesis to preclude death from accidental or intentional overdosage of a therapeutic composition. The surface of the therapeutic composition is coated with an...
|
|
|
4140756 |
Film-coated matrix core tablet
A tablet for controlled release of a water soluble medicament or dietary supplement is comprised of a water insoluble wax-like matrix core containing the water soluble medicament and coated with a...
|
|
|
4020005 |
Gelled reagent materials
Reagents can be provided in more convenient and readily-utilizable forms by converting the basic desired reagent material into a shapeable solid using gelation techniques (i.e., a non-crystalizing...
|
|
|
4013784 |
Delayed release pharmaceutical preparations
A novel delayed release pharmaceutical preparation which is free of added enzymes and thus is stable on storage is provided. The preparation comprises particles of the therapeutically effective...
|
|
|
3922338 |
Tablets containing in their mass controlled-release micro-capsules and process for manufacture of said tablets
The present invention relates to new tablets for administration of medicaments, which tablets contain in their mass, controlled-release microcapsules, that is to say elemental particles coated with...
|
|
|
3689634 |
PROTRACTED ACTIVITY ORAL HYDROGEL BEAD
Drugs are released gradually to a living organism after oral ingestion, through a layer of non-ionogenic, neutral hydrogel of a polymer of ethylene glycol methacrylate or similar monomer...
|
|
|
3431338 |
COATED DOSAGE FORM ADAPTED TO ORAL EMETINE OR DEHYDROEMETINE THERAPY
|
|
|
3371015 |
Pharmaceutical core compositions with thin rapidly disintegrating coatings
|
|
|
3345265 |
Multiple layer tablet with calcium salt central core separated from soluble fluoride outer coating
|
|
|
3297535 |
Shellac tablet coating compositions and methods of preparation
|
|
|
3266986 |
Hypnotic composition containing reaction product of chloral hydrate and acetylglycineamide
|
|
|
3198700 |
Sedative tablet and method for producing the same
|
|
|
3018221 |
Penicillin-sulfonamide tablet
|